Vertex Pharmaceuticals (VRTX) Net Income (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.41% |
| Dec 31, 2025 | 9.99% |
| Sep 30, 2025 | 4.84% |
| Jun 30, 2025 | 59.82% |
| Mar 31, 2025 | -29.21% |
| Dec 31, 2024 | -12.67% |
| Sep 30, 2024 | 129.09% |
| Jun 30, 2024 | -426.81% |
| Mar 31, 2024 | 13.50% |
| Dec 31, 2023 | -6.42% |
| Sep 30, 2023 | 13.06% |
| Jun 30, 2023 | 30.85% |
| Mar 31, 2023 | -14.54% |
| Dec 31, 2022 | -11.99% |
| Sep 30, 2022 | 14.81% |
| Jun 30, 2022 | 6.35% |
| Mar 31, 2022 | -1.04% |
| Dec 31, 2021 | -9.60% |
| Sep 30, 2021 | 1,171.49% |
| Jun 30, 2021 | -89.74% |
| Mar 31, 2021 | 8.10% |
| Dec 31, 2020 | -9.48% |
| Sep 30, 2020 | -20.28% |
| Jun 30, 2020 | 38.91% |
| Mar 31, 2020 | 3.35% |
| Dec 31, 2019 | 914.00% |
| Sep 30, 2019 | -78.49% |
| Jun 30, 2019 | -0.45% |
| Mar 31, 2019 | -82.39% |
| Dec 31, 2018 | 1,087.25% |
| Sep 30, 2018 | -37.72% |
| Jun 30, 2018 | -9.26% |
| Mar 31, 2018 | 122.44% |
| Dec 31, 2017 | 135.12% |
| Sep 30, 2017 | -1,033.52% |
| Jun 30, 2017 | -87.51% |
| Mar 31, 2017 | 798.98% |
| Dec 31, 2016 | 170.21% |
| Sep 30, 2016 | -9.37% |
| Jun 30, 2016 | -0.14% |
| Dec 31, 2014 | -226.56% |
| Sep 30, 2014 | 78.16% |
| Jun 30, 2014 | 15.32% |
| Mar 31, 2014 | 99.79% |
| Dec 31, 2013 | -2,170.42% |
| Sep 30, 2013 | -156.11% |
| Jun 30, 2013 | 50.90% |
| Mar 31, 2013 | 92.66% |
| Dec 31, 2012 | -194.99% |
| Sep 30, 2012 | 23.21% |
| Jun 30, 2012 | -139.22% |
| Mar 31, 2012 | -53.29% |
| Dec 31, 2011 | -17.65% |
| Mar 31, 2011 | 2.38% |
| Dec 31, 2010 | 13.67% |
| Sep 30, 2010 | -4.48% |
| Jun 30, 2010 | -22.12% |
| Mar 31, 2010 | -8.50% |
| Dec 31, 2009 | -0.93% |
| Sep 30, 2009 | 5.94% |
| Jun 30, 2009 | 2.26% |